In-depth coverage of the latest IP & Copyright developments, trends, and analysis — curated daily.
Picture this: Patent challengers filing IPRs at the USPTO, only to face denial rates surging like a firewall against foreign trolls. The institution rate? Down 43% in months.
Pro se inventor Brian McFadden's bid for an information exchange patent crashed hard Tuesday. Federal Circuit says it's just math on generic computers—no eligibility under Section 101.
A contractor scrolls UpCodes on his phone mid-job site chaos—no login, no fee, just the law as it stands. Another federal appeals court just made that reality stick, shredding private copyright claims on public rules.
Patents aren't waiting anymore. The USPTO just obliterated its backlog, unleashing a wave of innovation primed for AI's golden age.
Dreaming of IP academia but stuck in Big Law? GW's Frank H. Marks Fellowship might be your hidden accelerator. Low pay, high prestige—here's why it punches above its weight.
A $47 million jury hit on Texas ISP Grande Communications? SCOTUS just wiped it clean — for now. Remanded under Cox v. Sony's strict intent test, this could shield neutral pipes from labels' piracy policing demands.
Imagine Big Pharma's factories sprouting across Ohio rust belts overnight. Trump's bold EO demands it — or face crippling tariffs on patented drugs. But at what cost to your wallet?
Picture this: Pharma suits staring down generics reps in a USPTO room thick with tension. Patents aren't the villain—abusive PTAB tactics are.
A single missing inventor can now doom a patent forever. The Federal Circuit just proved it, striking down two patents in a ruling that exposes cracks in post-AIA law.
Picture Matthew McConaughey's drawl deciding your patent's fate: 'Alright, alright, alright.' USPTO just emailed that as an official April Fool's gag — and it's genius.
In a blow to patent holders, the Federal Circuit just ruled that 'allowing' a data packet counts as a patent claim's key 'action.' Centripetal's network security dreams? Dead on arrival.
Startups pouring cash into patents just got a rude wake-up. A single argument you make — and lose — during examination can torpedo your infringement suits years later.